Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|
Operating cash flow (Indirect Method) | |||
Cash from operating activities | 1,295.73%1.83B | -115.33%-153.26M | 999.94M |
Net profit before non-cash adjustment | -32.01%1.5B | 21.50%2.21B | --1.82B |
Total adjustment of non-cash items | -145.80%-18.4M | -47.05%40.17M | --75.88M |
-Depreciation and amortization | 6.33%70.87M | 24.66%66.66M | --53.47M |
-Share of associates | ---63.06M | --0 | ---- |
-Disposal profit | --20.99M | --0 | --0 |
-Net exchange gains and losses | 75.03%-9.14M | -237.37%-36.59M | ---10.85M |
-Other non-cash items | -476.42%-38.07M | -69.59%10.11M | --33.25M |
Changes in working capital | 114.58%350.11M | -168.94%-2.4B | ---892.75M |
-Change in receivables | -90.33%-203.52M | -221.46%-106.93M | ---33.26M |
-Provision for loans, leases and other losses | -97.12%2.62M | 152.13%90.88M | --36.05M |
-Changes in other current assets | 123.21%518.1M | -134.98%-2.23B | ---949.96M |
-Changes in other current liabilities | 121.55%32.9M | -380.55%-152.68M | --54.42M |
Dividends paid (cash flow from operating activities) | |||
Dividends received (cash flow from operating activities) | |||
Interest paid (cash flow from operating activities) | 22.07%-7.16M | 49.71%-9.19M | -18.27M |
Interest received (cash flow from operating activities) | 1,854.65%64.7M | -57.81%3.31M | 7.85M |
Tax refund paid | -240.55%-648.05M | 76.53%-190.29M | -810.91M |
Other operating cash inflow (outflow) | 0 | -1K | 0 |
Operating cash flow | 455.45%1.24B | -295.65%-349.43M | --178.6M |
Investing cash flow | |||
Net PPE purchase and sale | -132.63%-51.33M | 33.68%-22.07M | ---33.27M |
Net intangibles purchase and sale | 54.49%-841K | ---1.85M | --0 |
Net investment product transactions | 45.63%-14.4M | -164.89%-26.49M | ---10M |
Advance cash and loans provided to other parties | 99.20%-4.14M | ---520M | --0 |
Repayment of advance payments to other parties and cash income from loans | --520M | ---- | --292.4M |
Net changes in other investments | 484.06%48.56M | 41.38%-12.64M | ---21.57M |
Investing cash flow | 185.39%497.85M | -356.22%-583.05M | --227.56M |
Financing cash flow | |||
Net issuance payments of debt | -2,659.33%-843.5M | 92.66%-30.57M | ---416.45M |
Net common stock issuance | -50.43%-523.75M | -116.55%-348.17M | --2.1B |
Cash dividends paid | 1.96%-410.02M | -22.19%-418.23M | ---342.27M |
Net other fund-raising expenses | 3,679,900.00%36.8M | --1K | ---- |
Financing cash flow | -118.38%-1.74B | -159.23%-796.97M | --1.35B |
Net cash flow | |||
Beginning cash position | -36.08%2.94B | 63.86%4.6B | --2.81B |
Current changes in cash | 99.97%-566K | -198.73%-1.73B | --1.75B |
Effect of exchange rate changes | -9.54%61.66M | 125.74%68.16M | --30.2M |
Cash adjustments other than cash changes | -141,500.00%-1.41M | -99.99%1K | --12.59M |
End cash Position | 2.03%3B | -36.08%2.94B | --4.6B |
Free cash flow | 418.71%1.19B | -356.88%-373.34M | --145.34M |
Currency Unit | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |